annual cash & cash equivalents:
$97.88M+$51.41M(+110.64%)Summary
- As of today (May 29, 2025), PBH annual cash & cash equivalents is $97.88 million, with the most recent change of +$51.41 million (+110.64%) on March 31, 2025.
- During the last 3 years, PBH annual cash & cash equivalents has risen by +$70.70 million (+260.07%).
- PBH annual cash & cash equivalents is now at all-time high.
Performance
PBH Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$97.88M+$47.01M(+92.40%)Summary
- As of today (May 29, 2025), PBH quarterly cash & cash equivalents is $97.88 million, with the most recent change of +$47.01 million (+92.40%) on March 31, 2025.
- Over the past year, PBH quarterly cash & cash equivalents has increased by +$51.41 million (+110.64%).
- PBH quarterly cash & cash equivalents is now -40.18% below its all-time high of $163.62 million, reached on June 30, 2021.
Performance
PBH quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PBH Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +110.6% | +110.6% |
| 3 y3 years | +260.1% | +260.1% |
| 5 y5 years | +3.3% | +3.3% |
PBH Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +260.1% | at high | +260.1% |
| 5 y | 5-year | at high | +260.1% | -40.2% | +365.7% |
| alltime | all time | at high | +2784.9% | -40.2% | +2122.6% |
PBH Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $97.88M(+110.6%) | $97.88M(+92.4%) |
| Dec 2024 | - | $50.87M(-1.3%) |
| Sep 2024 | - | $51.54M(+50.5%) |
| Jun 2024 | - | $34.26M(-26.3%) |
| Mar 2024 | $46.47M(-20.6%) | $46.47M(-27.0%) |
| Dec 2023 | - | $63.62M(+5.9%) |
| Sep 2023 | - | $60.07M(+10.1%) |
| Jun 2023 | - | $54.58M(-6.7%) |
| Mar 2023 | $58.49M(+115.2%) | $58.49M(-32.3%) |
| Dec 2022 | - | $86.36M(+103.5%) |
| Sep 2022 | - | $42.44M(+18.3%) |
| Jun 2022 | - | $35.87M(+31.9%) |
| Mar 2022 | $27.18M(-15.8%) | $27.18M(+29.3%) |
| Dec 2021 | - | $21.02M(-50.9%) |
| Sep 2021 | - | $42.82M(-73.8%) |
| Jun 2021 | - | $163.62M(+406.5%) |
| Mar 2021 | $32.30M(-65.9%) | $32.30M(-48.0%) |
| Dec 2020 | - | $62.10M(+133.4%) |
| Sep 2020 | - | $26.60M(-54.1%) |
| Jun 2020 | - | $57.94M(-38.9%) |
| Mar 2020 | $94.76M(+244.2%) | $94.76M(+231.4%) |
| Dec 2019 | - | $28.59M(+2.5%) |
| Sep 2019 | - | $27.91M(-3.9%) |
| Jun 2019 | - | $29.04M(+5.5%) |
| Mar 2019 | $27.53M(-15.4%) | $27.53M(+11.6%) |
| Dec 2018 | - | $24.67M(-33.2%) |
| Sep 2018 | - | $36.91M(+7.7%) |
| Jun 2018 | - | $34.27M(+5.3%) |
| Mar 2018 | $32.55M(-22.2%) | $32.55M(-28.3%) |
| Dec 2017 | - | $45.38M(+5.6%) |
| Sep 2017 | - | $42.98M(-2.6%) |
| Jun 2017 | - | $44.13M(+5.4%) |
| Mar 2017 | $41.85M(+53.7%) | $41.85M(-33.9%) |
| Dec 2016 | - | $63.29M(+107.8%) |
| Sep 2016 | - | $30.46M(+5.5%) |
| Jun 2016 | - | $28.88M(+6.0%) |
| Mar 2016 | $27.23M(+27.7%) | $27.23M(-44.4%) |
| Dec 2015 | - | $48.97M(+121.1%) |
| Sep 2015 | - | $22.15M(+2.6%) |
| Jun 2015 | - | $21.60M(+1.3%) |
| Mar 2015 | $21.32M | $21.32M(-2.9%) |
| Dec 2014 | - | $21.95M(+0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $21.75M(+38.7%) |
| Jun 2014 | - | $15.68M(-44.7%) |
| Mar 2014 | $28.33M(+80.8%) | $28.33M(-70.0%) |
| Dec 2013 | - | $94.35M(+251.6%) |
| Sep 2013 | - | $26.83M(+39.0%) |
| Jun 2013 | - | $19.31M(+23.2%) |
| Mar 2013 | $15.67M(-17.6%) | $15.67M(+50.2%) |
| Dec 2012 | - | $10.43M(-64.0%) |
| Sep 2012 | - | $29.01M(+558.6%) |
| Jun 2012 | - | $4.40M(-76.8%) |
| Mar 2012 | $19.02M(+42.6%) | $19.02M(+328.4%) |
| Dec 2011 | - | $4.44M(-44.2%) |
| Sep 2011 | - | $7.96M(+32.9%) |
| Jun 2011 | - | $5.99M(-55.1%) |
| Mar 2011 | $13.33M(-67.6%) | $13.33M(-84.0%) |
| Dec 2010 | - | $83.27M(+51.3%) |
| Sep 2010 | - | $55.03M(+66.2%) |
| Jun 2010 | - | $33.11M(-19.4%) |
| Mar 2010 | $41.10M(+16.8%) | $41.10M(+19.9%) |
| Dec 2009 | - | $34.26M(-1.6%) |
| Sep 2009 | - | $34.83M(-3.7%) |
| Jun 2009 | - | $36.15M(+2.8%) |
| Mar 2009 | $35.18M(+478.8%) | $35.18M(+25.9%) |
| Dec 2008 | - | $27.93M(+121.2%) |
| Sep 2008 | - | $12.63M(+98.3%) |
| Jun 2008 | - | $6.37M(+4.8%) |
| Mar 2008 | $6.08M(-55.8%) | $6.08M(-47.4%) |
| Dec 2007 | - | $11.55M(+31.3%) |
| Sep 2007 | - | $8.80M(+42.7%) |
| Jun 2007 | - | $6.16M(-55.2%) |
| Mar 2007 | $13.76M(+67.8%) | $13.76M(+186.5%) |
| Dec 2006 | - | $4.80M(-54.3%) |
| Sep 2006 | - | $10.51M(-51.0%) |
| Jun 2006 | - | $21.46M(+161.7%) |
| Mar 2006 | $8.20M(+53.7%) | $8.20M(-15.0%) |
| Dec 2005 | - | $9.65M(-65.0%) |
| Sep 2005 | - | $27.59M(+97.8%) |
| Jun 2005 | - | $13.95M(+161.4%) |
| Mar 2005 | $5.33M(+57.2%) | $5.33M(-21.0%) |
| Dec 2004 | - | $6.75M |
| Mar 2004 | $3.39M(-3.9%) | - |
| Mar 2003 | $3.53M(-55.2%) | - |
| Mar 2002 | $7.88M | - |
FAQ
- What is Prestige Consumer Healthcare annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Prestige Consumer Healthcare?
- What is Prestige Consumer Healthcare annual cash & cash equivalents year-on-year change?
- What is Prestige Consumer Healthcare quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Prestige Consumer Healthcare?
- What is Prestige Consumer Healthcare quarterly cash & cash equivalents year-on-year change?
What is Prestige Consumer Healthcare annual cash & cash equivalents?
The current annual cash & cash equivalents of PBH is $97.88M
What is the all time high annual cash & cash equivalents for Prestige Consumer Healthcare?
Prestige Consumer Healthcare all-time high annual cash & cash equivalents is $97.88M
What is Prestige Consumer Healthcare annual cash & cash equivalents year-on-year change?
Over the past year, PBH annual cash & cash equivalents has changed by +$51.41M (+110.64%)
What is Prestige Consumer Healthcare quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PBH is $97.88M
What is the all time high quarterly cash & cash equivalents for Prestige Consumer Healthcare?
Prestige Consumer Healthcare all-time high quarterly cash & cash equivalents is $163.62M
What is Prestige Consumer Healthcare quarterly cash & cash equivalents year-on-year change?
Over the past year, PBH quarterly cash & cash equivalents has changed by +$51.41M (+110.64%)